186 related articles for article (PubMed ID: 28057758)
1. Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells.
Hichino A; Okamoto M; Taga S; Akizuki R; Endo S; Matsunaga T; Ikari A
J Biol Chem; 2017 Feb; 292(6):2411-2421. PubMed ID: 28057758
[TBL] [Abstract][Full Text] [Related]
2. Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells.
Sonoki H; Sato T; Endo S; Matsunaga T; Yamaguchi M; Yamazaki Y; Sugatani J; Ikari A
Nutrients; 2015 Jun; 7(6):4578-92. PubMed ID: 26061016
[TBL] [Abstract][Full Text] [Related]
3. Caffeic acid phenethyl ester down-regulates claudin-2 expression at the transcriptional and post-translational levels and enhances chemosensitivity to doxorubicin in lung adenocarcinoma A549 cells.
Sonoki H; Tanimae A; Furuta T; Endo S; Matsunaga T; Ichihara K; Ikari A
J Nutr Biochem; 2018 Jun; 56():205-214. PubMed ID: 29597147
[TBL] [Abstract][Full Text] [Related]
4. Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells.
Shimobaba S; Taga S; Akizuki R; Hichino A; Endo S; Matsunaga T; Watanabe R; Yamaguchi M; Yamazaki Y; Sugatani J; Ikari A
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1170-8. PubMed ID: 26919807
[TBL] [Abstract][Full Text] [Related]
5. Decrease in paracellular permeability and chemosensitivity to doxorubicin by claudin-1 in spheroid culture models of human lung adenocarcinoma A549 cells.
Akizuki R; Maruhashi R; Eguchi H; Kitabatake K; Tsukimoto M; Furuta T; Matsunaga T; Endo S; Ikari A
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):769-780. PubMed ID: 29524521
[TBL] [Abstract][Full Text] [Related]
6. Effects of histone deacetylase inhibitors Tricostatin A and Quisinostat on tight junction proteins of human lung adenocarcinoma A549 cells and normal lung epithelial cells.
Shindo Y; Arai W; Konno T; Kohno T; Kodera Y; Chiba H; Miyajima M; Sakuma Y; Watanabe A; Kojima T
Histochem Cell Biol; 2021 Jun; 155(6):637-653. PubMed ID: 33974136
[TBL] [Abstract][Full Text] [Related]
7. Down-Regulation of Claudin-2 Expression by Cyanidin-3-Glucoside Enhances Sensitivity to Anticancer Drugs in the Spheroid of Human Lung Adenocarcinoma A549 Cells.
Eguchi H; Matsunaga H; Onuma S; Yoshino Y; Matsunaga T; Ikari A
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419064
[TBL] [Abstract][Full Text] [Related]
8. Kaempherol and Luteolin Decrease Claudin-2 Expression Mediated by Inhibition of STAT3 in Lung Adenocarcinoma A549 Cells.
Sonoki H; Tanimae A; Endo S; Matsunaga T; Furuta T; Ichihara K; Ikari A
Nutrients; 2017 Jun; 9(6):. PubMed ID: 28608828
[TBL] [Abstract][Full Text] [Related]
9. Elevation of sensitivity to anticancer agents of human lung adenocarcinoma A549 cells by knockdown of claudin-2 expression in monolayer and spheroid culture models.
Maruhashi R; Akizuki R; Sato T; Matsunaga T; Endo S; Yamaguchi M; Yamazaki Y; Sakai H; Ikari A
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):470-479. PubMed ID: 29247669
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.
El-Awady RA; Hersi F; Al-Tunaiji H; Saleh EM; Abdel-Wahab AH; Al Homssi A; Suhail M; El-Serafi A; Al-Tel T
Cancer Biol Ther; 2015; 16(7):1056-70. PubMed ID: 25962089
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.
Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1927-46. PubMed ID: 27393180
[TBL] [Abstract][Full Text] [Related]
12. ZO-2 Suppresses Cell Migration Mediated by a Reduction in Matrix Metalloproteinase 2 in Claudin-18-Expressing Lung Adenocarcinoma A549 Cells.
Akizuki R; Eguchi H; Endo S; Matsunaga T; Ikari A
Biol Pharm Bull; 2019; 42(2):247-254. PubMed ID: 30713254
[TBL] [Abstract][Full Text] [Related]
13. Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells.
Ikari A; Sato T; Watanabe R; Yamazaki Y; Sugatani J
Biochim Biophys Acta; 2012 Jun; 1823(6):1110-8. PubMed ID: 22546605
[TBL] [Abstract][Full Text] [Related]
14. The Roles and Regulatory Mechanisms of Tight Junction Protein Cingulin and Transcription Factor Forkhead Box Protein O1 in Human Lung Adenocarcinoma A549 Cells and Normal Lung Epithelial Cells.
Ishii D; Shindo Y; Arai W; Konno T; Kohno T; Honda K; Miyajima M; Watanabe A; Kojima T
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338691
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells.
Arai W; Konno T; Kohno T; Kodera Y; Tsujiwaki M; Shindo Y; Chiba H; Miyajima M; Sakuma Y; Watanabe A; Kojima T
Oncotarget; 2023 Mar; 14():261-275. PubMed ID: 36961882
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
[TBL] [Abstract][Full Text] [Related]
17.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
18. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
19. Quinacrine Inhibits ICAM-1 Transcription by Blocking DNA Binding of the NF-κB Subunit p65 and Sensitizes Human Lung Adenocarcinoma A549 Cells to TNF-α and the Fas Ligand.
Harada M; Morimoto K; Kondo T; Hiramatsu R; Okina Y; Muko R; Matsuda I; Kataoka T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207489
[TBL] [Abstract][Full Text] [Related]
20. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
